# Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

> **NCT01051960** · PHASE4 · COMPLETED · sponsor: **University of California, Los Angeles** · enrollment: 12 (actual)

## Conditions studied

- Systemic Sclerosis
- Shortness of Breath
- Pulmonary Hypertension

## Interventions

- **DRUG:** Ambrisentan

## Key facts

- **NCT ID:** NCT01051960
- **Lead sponsor:** University of California, Los Angeles
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03
- **Primary completion:** 2010-06
- **Final completion:** 2011-01
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2020-11-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01051960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01051960, "Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01051960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*